The Help for Hay Fever Study

Not Applicable

Completed

• Conditions: Allergic rhinitis, unspecified; Intermittent Allergic Rhinitis (Hay Fever); Respiratory

• Registration Number: ISRCTN43606442
• Lead Sponsor: niversity of Aberdeen (UK)

Brief Summary

2013 protocol in http://www.ncbi.nlm.nih.gov/pubmed/23856015

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-06-18
• Study Completion: 2012-09-30
• Last Update Posted: 25 March 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 144

Inclusion Criteria

Community pharmacies, from the two nominated study areas in Scotland, with staff available to attend training if randomised to the intervention group.

Community pharmacy customers who:
1. Present opportunistically in participating community pharmacies
2. Have a history of intermittent allergic rhinitis i.e. experience symptoms on =4 days per week OR <4 weeks
3. Are currently experiencing symptoms of allergic rhinitis, defined as 2 or more of the following symptoms for =1 hour on most days: runny nose with both sides affected, blocked nose on both sides, itchy nose, sudden bouts of sneezing,sore, red, itchy eyes, itchy throat.
4. Are 18 years of age or over
5. Are able to speak, write and understand English

Exclusion Criteria

Community pharmacies, from the two nominated study areas in Scotland, whose staff are not available to attend training if randomised to the intervention group.

Community pharmacy customers who:
1. Present with any of the following symptoms: blocked nose with no other symptoms suggestive of hay fever, thick yellow or green nose discharge, thick mucus at the back of the throat, sinus pain, recurrent nose bleeds, loss of smell.
2. Are under 18 years of age
3. Are unable to speak, write or understand English
4. Are pregnant
5. Are terminally ill
6. Have participated in another hay fever study within the last two years

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Outcome measures have been selected to represent a range of clinical indicators and social functioning that are relevant to allergic rhinitis.<br> Quality of Life (QOL), measured using a validated and widely used disease specific health status instrument (mini Rhinoconjunctivitis Quality of Life Questionnaire- miniRQLQ, (Juniper, 2000)), whose ?psychometric properties and minimally clinically important difference? are well described. QOL will be measured by questionnaire on the day of recruitment, and one week and six weeks after recruitment.<br>